It’s been 18 years since the last drug was approved for Alzheimer’s, but on Monday, June 7, 2021, the FDA gave “Accelerated Approval” to Biogen’s novel medication, Aducanumab (“Aduhelm”).  The …

Aducanumab – Is this the end of Alzheimer’s? Not just yet… Read More »